- Systematic inclusion of cost-benefit analyses in clinical trials with collection of health economic analysis such as incremental cost effectiveness ratio in order to facilitate clinical decision-making.
- Predictive biomarkers: response to specific systemic targeted therapies and immunotherapy.
- Improve models for pre-clinical testing of novel drugs.
- Search for tools to assess quality of life and in clinical trials.
- Dietary supplements, nutritional counselling, physical activity recommendations and psychological support as part of an integrative healthcare approach to care for people with gastric cancer.